Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695642 · ClinicalTrials.gov registry record
Long-term LASIK Follow up Study
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 51
- Enrollment target
NCT01695642: Completed study, sponsored by University of Michigan.
NCT01695642 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01695642 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
Laser in situ keratomileusis (LASIK) is the most common corneal refractive surgery performed for correction of myopia. There are very few studies that have been performed to evaluate long-term outcomes after LASIK. In this study, we will assess long-term outcomes 5 - 10 years after LASIK to assess stability of visual outcomes and long-term effect on corneal morphology with in vivo confocal microscopy. Clinical and corneal morphology outcomes will also be compared between patients who had flaps created with the microkeratome and femtosecond laser.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-12 |
What the finished NCT01695642 record still lists
NCT01695642 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01695642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01695642 about?
NCT01695642 is a clinical study titled "Long-term LASIK Follow up Study". Laser in situ keratomileusis (LASIK) is the most common corneal refractive surgery performed for correction of myopia. There are very few studies that have been performed to evaluate long-term outcomes after LASIK. In this study, we will assess long-term outcomes 5 - 10 years after LASIK to assess ...
What is the current status of trial NCT01695642?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2011-06. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01695642?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia